Concepedia
Publication | Open Access
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
435
Citations
18
References
2020
Year
ClinicalTrials.gov Identifier: NCT02829918.
Page 1